Enanta Pharmaceuticals, Inc. (ENTA)

Enanta Pharmaceuticals Revenue

Enanta Pharmaceuticals had revenue of $73.62M in the twelve months ending December 31, 2023, down -10.32% year-over-year. Revenue in the quarter ending December 31, 2023 was $18.00M, a -23.67% decrease year-over-year. In the fiscal year ending September 30, 2023, Enanta Pharmaceuticals had annual revenue of $79.20M, a decrease of -8.07%.

• Revenue (ttm): $73.62M
• Revenue Growth: -10.32%
• P/S Ratio: 4.00
• Revenue / Employee: $507,738
• Employees: 145
• Market Cap: 294.28M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2023	79.20M	-6.96M	-8.07%
Sep 30, 2022	86.16M	-10.91M	-11.24%
Sep 30, 2021	97.07M	-25.40M	-20.74%
Sep 30, 2020	122.47M	-82.72M	-40.31%
Sep 30, 2019	205.20M	-1.43M	-0.69%
Sep 30, 2018	206.63M	103.81M	100.97%
Sep 30, 2017	102.81M	14.55M	16.48%
Sep 30, 2016	88.27M	-72.61M	-45.13%
Sep 30, 2015	160.88M	113.14M	236.98%
Sep 30, 2014	47.74M	15.69M	48.94%
Sep 30, 2013	32.05M	-9.65M	-23.15%
Sep 30, 2012	41.71M	-176.00K	-0.42%
Sep 30, 2011	41.88M	19.12M	83.99%
Sep 30, 2010	22.76M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.